Zipbio

Developer of AI-driven platform creating de novo genes and protein therapeutics

placeSeattle, Washington, United States calendar_todayFounded 2023 language ziptx.bio

Social engagement: 1.6K social following, 1 post in the last 12 months — below the industry typical range.

2 investors on record; lead investors include NFX.

Investor type	Count	Share
Venture capital	2	100%

3 Feb 2026

Partnership

MeiraGTx (Nasdaq: MGTX)

Coming soon